In a study presented in the featured clinical investigation
article of the November issue
of The Journal
of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount
of cell - free tumor DNA circulating in the bloodstream correlates with tumor
metabolism (linked to cancer aggressiveness), not tumor burden (amount
of cancer in the body).